Staffan Schüberg
Director/Board Member presso SWEDISH ORPHAN BIOVITRUM AB
Patrimonio netto: 165 125 $ in data 29/02/2024
Profilo
Staffan Schüberg is a Swedish businessperson who has been at the helm of 6 different companies and currently is Chief Executive Officer for Corporación Químico Farmaceútica Esteve SA, Chief Executive Officer & Director at Esteve Pharmaceuticals S.A.
(a subsidiary of Corporación Químico Farmaceútica Esteve SA) and Chief Executive Officer & Director at Esteve Healthcare SL.
He is also on the board of 5 other companies.
Staffan Schüberg previously occupied the position of President for Lundbeck USA Inc., Chairman & President at Lundbeck, Inc. (Illinois), President & Director at Chelsea Therapeutics International Ltd., Chief Commercial Officer & Executive VP at H.
Lundbeck An and Managing Director at Lundbeck Portugal Produtos Farmaceuticos Unipessoal Ltda.
He received an undergraduate degree from London Guildhall University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
12/09/2023 | 6 711 ( 0.00% ) | 165 125 $ | 29/02/2024 |
Posizioni attive di Staffan Schüberg
Società | Posizione | Inizio |
---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Director/Board Member | 01/01/2020 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Director/Board Member | 22/12/2010 |
Dizlin Medical Design AB
Dizlin Medical Design AB Pharmaceuticals: MajorHealth Technology Dizlin Medical Design AB manufactures pharmaceutical products. The private company is based in Vimmerby, Sweden. | Director/Board Member | - |
Esteve Pharmaceuticals S.A.
Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Chief Executive Officer | - |
Pensa Investments SL
Pensa Investments SL Miscellaneous Commercial ServicesCommercial Services Pensa Investments SL engages in the manufacture of pharmaceutical facilities. The firm specializes in the research, production, development, storage, lease, commercialization, and sale of raw materials and property. The company was founded on December 20, 2019 and is headquartered in Martorelles, Spain. | Director/Board Member | 24/01/2020 |
Corporación Químico Farmaceútica Esteve SA
Corporación Químico Farmaceútica Esteve SA Pharmaceuticals: MajorHealth Technology Corporación QuÃmico Farmacéutica Esteve SA is a pharmaceutical company based in Barcelona, ES. and has subsidiaries in the Europe and Americas regions. Esteve manufactures and distributes pharmaceutical products. The Spanish company was founded in 1986 and the CEO is Staffan Schüberg. | Chief Executive Officer | - |
Dizlin Pharmaceuticals AB | Director/Board Member | - |
Esteve Healthcare SL
Esteve Healthcare SL Pharmaceuticals: MajorHealth Technology Esteve Healthcare SL is a Spanish international specialty pharma company that has experienced significant growth in 2022, expanding its presence in Europe and beyond. Esteve Healthcare is based in Barcelona, ES, and has subsidiaries in Germany. The company has launched an inhaled treatment for off periods in Parkinson's disease and is collaborating with Medtronic to improve the pathway of patients with refractory cancer pain. The company was founded in 1929 by Antoni Esteve Subirana, and Staffan Schüberg has been the CEO of the company since 2019. | Chief Executive Officer | 01/01/2019 |
Precedenti posizioni note di Staffan Schüberg
Società | Posizione | Fine |
---|---|---|
H. LUNDBECK A/S | Corporate Officer/Principal | 31/10/2017 |
░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ | - |
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formazione di Staffan Schüberg
London Guildhall University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
H. LUNDBECK A/S | Health Technology |
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
Aziende private | 12 |
---|---|
Chelsea Therapeutics International Ltd.
Chelsea Therapeutics International Ltd. BiotechnologyHealth Technology Chelsea Therapeutics International Ltd. acquires, develops and commercializes innovative products for the treatment of a variety of human diseases. The company was founded by Simon C. Pedder on June 17, 2005 and is headquartered in Charlotte, NC. | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
Lundbeck, Inc. (Illinois) | |
Lundbeck USA Inc. | |
Corporación Químico Farmaceútica Esteve SA
Corporación Químico Farmaceútica Esteve SA Pharmaceuticals: MajorHealth Technology Corporación QuÃmico Farmacéutica Esteve SA is a pharmaceutical company based in Barcelona, ES. and has subsidiaries in the Europe and Americas regions. Esteve manufactures and distributes pharmaceutical products. The Spanish company was founded in 1986 and the CEO is Staffan Schüberg. | Health Technology |
Hangzhou Jiuyuan Gene Engineering Co. Ltd.
Hangzhou Jiuyuan Gene Engineering Co. Ltd. Pharmaceuticals: MajorHealth Technology Hangzhou Jiuyuan Gene Engineering Co. Ltd. operates as a biopharmaceutical company. It specializes in R&D, manufacturing and commercialization of biopharmaceutical products and medical devices. Hangzhou Jiuyuan therapeutic includes orthopedics, metabolic diseases, oncology, and hematology services. The company was founded on December 31, 1993 and is headquartered in Hangzhou, China. | Health Technology |
Dizlin Medical Design AB
Dizlin Medical Design AB Pharmaceuticals: MajorHealth Technology Dizlin Medical Design AB manufactures pharmaceutical products. The private company is based in Vimmerby, Sweden. | Health Technology |
Esteve Pharmaceuticals S.A.
Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Health Technology |
Dizlin Pharmaceuticals AB | |
Pensa Investments SL
Pensa Investments SL Miscellaneous Commercial ServicesCommercial Services Pensa Investments SL engages in the manufacture of pharmaceutical facilities. The firm specializes in the research, production, development, storage, lease, commercialization, and sale of raw materials and property. The company was founded on December 20, 2019 and is headquartered in Martorelles, Spain. | Commercial Services |
Esteve Healthcare SL
Esteve Healthcare SL Pharmaceuticals: MajorHealth Technology Esteve Healthcare SL is a Spanish international specialty pharma company that has experienced significant growth in 2022, expanding its presence in Europe and beyond. Esteve Healthcare is based in Barcelona, ES, and has subsidiaries in Germany. The company has launched an inhaled treatment for off periods in Parkinson's disease and is collaborating with Medtronic to improve the pathway of patients with refractory cancer pain. The company was founded in 1929 by Antoni Esteve Subirana, and Staffan Schüberg has been the CEO of the company since 2019. | Health Technology |
Lundbeck Portugal Produtos Farmaceuticos Unipessoal Ltda. |